Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Monitoring and evaluation of breast cancer screening programmes : selecting candidate performance indicators

Autor: Muratov, Sergei, Canelo-Aybar, Carlos, Tarride, Jean-Eric, Alonso-Coello, Pablo, Dimitrova, Nadya, Borisch, Bettina, Castells, Xavier, Duffy, Stephen W., Fitzpatrick, Patricia, Follmann, Markus, Giordano, Livia, Hofvind, Solveig, Lebeau, Annette, Quinn, Cecily, Torresin, Alberto, Vialli, Claudia, Siesling, Sabine, Ponti, Antonio, Giorgi Rossi, Paolo, Schünemann, Holger, Nyström, Lennarth, Broeders, Mireille, Autelitano, Mariangela, Colzani, Edoardo, Daneš, Jan, Gräwingholt, Axel, Ioannidou-Mouzaka, Lydia, Knox, Susan, Langendam, Miranda, McGarrigle, Helen, Pérez Gómez, Elsa, van Engen, Ruben, Warman, Sue, Young, Kenneth, van Landsveld-Verhoeven, Cary, Lerda, Donata, Saz-Parkinson, Zuleika, Parmelli, Elena, Janusch-Roi, Annett

Publikováno v: BMC CANCER
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
BMC cancer, 20(1):795. BioMed Central
BMC Cancer
BMC cancer, 20:795. BioMed Central
BMC Cancer, 20
BMC Cancer, 20, 1

Background In the scope of the European Commission Initiative on Breast Cancer (ECIBC) the Monitoring and Evaluation (M&E) subgroup was tasked to identify breast cancer screening programme (BCSP) performance indicators, including their acceptable and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdf1f1049df9d2543a9d47bb899552df
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-175823

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative.

Autor: Giorgi Rossi P; Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Lebeau A; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Canelo-Aybar C; Iberoamerican Cochrane Center, Biomedical Research Institute (IIB Sant Pau-CIBERESP), Barcelona, Spain.; Department of Paediatrics, Obstetrics and Gynaecology, Preventive Medicine, and Public Health, PhD Programme in Methodology of Biomedical Research and Public Health, Universitat Autònoma de Barcelona, Bellaterra, Spain., Saz-Parkinson Z; European Commission, Joint Research Centre (JRC), Ispra, Italy. zuleika.saz-parkinson@ec.europa.eu.; Instituto de Salud Carlos III, Health Technology Assessment Agency, Avenida Monforte de Lemos 5, Madrid, Spain. zuleika.saz-parkinson@ec.europa.eu., Quinn C; St. Vincent's University Hospital, Dublin, Ireland., Langendam M; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Institute, Amsterdam, The Netherlands., Mcgarrigle H; Cardiff and Vale UHB - General Surgery, Cardiff, UK., Warman S; Havyatt Lodge, Havyatt Road, Langford, North Somerset, UK., Rigau D; Iberoamerican Cochrane Center, Biomedical Research Institute (IIB Sant Pau-CIBERESP), Barcelona, Spain., Alonso-Coello P; Iberoamerican Cochrane Center, Biomedical Research Institute (IIB Sant Pau-CIBERESP), Barcelona, Spain., Broeders M; Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands.; Dutch Expert Centre for Screening, Nijmegen, the Netherlands., Graewingholt A; Radiologie am Theater, Paderborn, NRW, Germany., Posso M; Iberoamerican Cochrane Center, Biomedical Research Institute (IIB Sant Pau-CIBERESP), Barcelona, Spain.; Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Research Network on Health Services in Chronic Diseases (REDISSEC), Barcelona, Spain., Duffy S; Centre for Cancer Prevention, Queen Mary University of London, Charterhouse Square, London, UK., Schünemann HJ; Michael G. DeGroote Cochrane Canada and McGRADE Centres; Department of Health Research Methods, Evidence and Impact, McMaster University Health Sciences Centre, Hamilton, Ontario, Canada.

Publikováno v: British journal of cancer [Br J Cancer] 2021 Apr; Vol. 124 (9), pp. 1503-1512. Date of Electronic Publication: 2021 Feb 18.